Home › Sakit na Sjögren › California
Pag-aaral pangklinika para sa Sakit na Sjögren sa California
6 pag-aaral para sa Sakit na Sjögren ang naghahanap ng mga kalahok sa mga site sa California.
Opisyal na teksto ng pag-aaral (English)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03816345The Myelin Disorders Biorepository Project
- Children's Hospital of Los Angeles, Los Angeles
- Children's Hospital of Orange County, Orange
- Stanford University (Lucile Packard Children's Hospital), Palo Alto
- at 3 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03047369Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Medvin Clinical Research, Van Nuys
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07621809Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Wallace Rheumatic Study Center, Beverly Hills
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07404865AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Chula Vista, Chula Vista
- Artiva Investigational Site Covina, Covina
- Artiva Investigational Site Los Alamitos, Los Alamitos
- at 3 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06991114A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Samy Metyas MD Inc, Covina
- UCSD Altman Clinical and Translational Research Institute Building, La Jolla
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT06747949Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.